my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
01-09-2008: Hikal Ltd. announced that it has completed a contract manufacturing agreement for supply of active pharmaceutical ingredients (API's) with Pfizer Inc.
"We are extremely pleased to be selected as a long term contract manufacturer by Pfizer", said Jai Hiremath, Vice Chairman & Managing Director of Hikal Ltd. "This agreement will have a substantial impact on our Pharmaceutical business in the coming years".
"We look forward to working with Hikal, a respected contract manufacturing company and are delighted that they are able to contribute towards supply of APIs for Pfizer products", said Mr. Peter Stevenson, Vice-President, Global Contract Manufacturing, Procurement and Pfizer Center Source, Pfizer Inc.
Terms of the agreement were not disclosed.
Watchlist
This is where you can add this news to your personal favourites
Chemists synthesize herbal alkaloid
The club moss Lycopodium serratum is a creeping, flowerless plant used in homeopathic medicine to treat a wide variety of ailments. It contains a potent brew of alkaloids that have attracted considerable scientific and medical interest. However, the plant makes many of these compounds in ex ... more
EPA Honors Pfizer for Reducing Greenhouse Gas Emissions
The U.S. Environmental Protection Agency (EPA) honored Pfizer Inc in recognition of the company’s award-winning Energy and Climate Change Program, which reduced total greenhouse gas emissions by 43 percent per million dollars of revenue from 2000 to 2007. These reductions, which exceeded P ... more
Hikal signs a manufacturing agreement with Pfizer
Hikal Ltd. announced that it has completed a contract manufacturing agreement for supply of active pharmaceutical ingredients (API's) with Pfizer Inc. "We are extremely pleased to be selected as a long term contract manufacturer by Pfizer", said Jai Hiremath, Vice Chairman & Managing Direc ... more
Hikal appoints Dr. Vadiraj Ekkundi as Head - R&D, Bangalore
Hikal Ltd. announced the appointment of Dr. Vadiraj Ekkundi as the Head of its R&D facility in Bangalore. Dr. Ekkundi comes with over 26 years of experience in the field of Research & Development activities. His experience encompasses a mix of scientific, technical as well as managerial r ... more
Hikal signs a manufacturing agreement with Pfizer
Hikal Ltd. announced that it has completed a contract manufacturing agreement for supply of active pharmaceutical ingredients (API's) with Pfizer Inc. "We are extremely pleased to be selected as a long term contract manufacturer by Pfizer", said Jai Hiremath, Vice Chairman & Managing Direc ... more
Degussa and Hikal sign manufacturing agreement
The Exclusive Synthesis & Catalysts business unit of Degussa AG, Dusseldorf, Germany, has announced that it has signed a long-term, non-exclusive agreement with Hikal Ltd., India, for a cooperation on the manufacture of pharmaceutical intermediates and APIs. Under this agreement Degussa wil ... more
Hikal is a reliable long-term outsourcing partner to companies in the Pharmaceuticals, Agrochemicals and Specialty Chemicals industry. The company has been supplying key APIs and intermediates, manufactured using stringent global quality standards, for it’s customers in the United States, ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2011 CHEMIE.DE Information Service GmbH, All rights reserved
